BIOINVENT INTERNATIONAL AB NPVBIOINVENT INTERNATIONAL AB NPVBIOINVENT INTERNATIONAL AB NPV

BIOINVENT INTERNATIONAL AB NPV

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
Revenue estimate
Market capitalization
‪1.77 B‬SEK
−5.10SEK
‪−330.30 M‬SEK
‪71.46 M‬SEK
‪43.18 M‬
Beta (1Y)
0.52

About BIOINVENT INTERNATIONAL AB

CEO
Martin Welschof
Headquarters
Lund
Employees (FY)
111
Founded
1997
ISIN
SE0015244520
FIGI
BBG00YJVH3V7
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. Its technology platforms include F.I.R.S.T. and n-CoDeR. The company was founded in 1996 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0H22 is 26.55 SEK — it has decreased by 0.56% in the past 24 hours. Watch BIOINVENT INTERNATIONAL AB NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange BIOINVENT INTERNATIONAL AB NPV stocks are traded under the ticker 0H22.
BIOINVENT INTERNATIONAL AB NPV is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
0H22 stock is 0.57% volatile and has beta coefficient of 0.52. Track BIOINVENT INTERNATIONAL AB NPV stock price on the chart and check out the list of the most volatile stocks — is BIOINVENT INTERNATIONAL AB NPV there?
0H22 earnings for the last quarter are −1.00 SEK per share, whereas the estimation was −1.17 SEK resulting in a 14.62% surprise. The estimated earnings for the next quarter are −1.25 SEK per share. See more details about BIOINVENT INTERNATIONAL AB NPV earnings.
BIOINVENT INTERNATIONAL AB NPV revenue for the last quarter amounts to ‪13.00 M‬ SEK despite the estimated figure of ‪9.00 M‬ SEK. In the next quarter revenue is expected to reach ‪8.00 M‬ SEK.
Yes, you can track BIOINVENT INTERNATIONAL AB NPV financials in yearly and quarterly reports right on TradingView.
0H22 stock has risen by 6.63% compared to the previous week, the month change is a 49.86% rise, over the last year BIOINVENT INTERNATIONAL AB NPV has showed a 3.98% decrease.
0H22 net income for the last quarter is ‪−77.95 M‬ SEK, while the quarter before that showed ‪−97.16 M‬ SEK of net income which accounts for 19.77% change. Track more BIOINVENT INTERNATIONAL AB NPV financial stats to get the full picture.
Today BIOINVENT INTERNATIONAL AB NPV has the market capitalization of ‪1.77 B‬, it has decreased by 3.13% over the last week.
No, 0H22 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0H22 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOINVENT INTERNATIONAL AB NPV stock right from TradingView charts — choose your broker and connect to your account.
0H22 reached its all-time high on May 27, 2010 with the price of 690.15 SEK, and its all-time low was 14.35 SEK and was reached on Nov 1, 2023. View more price dynamics on 0H22 chart.
See other stocks reaching their highest and lowest prices.
As of May 6, 2024, the company has 111.00 employees. See our rating of the largest employees — is BIOINVENT INTERNATIONAL AB NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOINVENT INTERNATIONAL AB NPV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOINVENT INTERNATIONAL AB NPV stock shows the neutral signal. See more of BIOINVENT INTERNATIONAL AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOINVENT INTERNATIONAL AB NPV future price: according to them, 0H22 price has a max estimate of 30.00 SEK and a min estimate of 30.00 SEK. Watch 0H22 chart and read a more detailed BIOINVENT INTERNATIONAL AB NPV stock forecast: see what analysts think of BIOINVENT INTERNATIONAL AB NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOINVENT INTERNATIONAL AB NPV EBITDA is ‪−362.09 M‬ SEK, and current EBITDA margin is −495.13%. See more stats in BIOINVENT INTERNATIONAL AB NPV financial statements.